(Q40011300)

English

Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol

scientific article published on 20 February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

author name string

Zengshuan Ma

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Ommoleila Molavi

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Azita Haddadi

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Raymond Lai

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Robert A Gossage

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Afsaneh Lavasanifar

6

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

20 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

27-35

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

https://scigraph.springernature.com/pub.10.1007/s00280-008-0704-z

0 references

Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS00280-008-0704-Z

21 January 2018

Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation

1 reference

https://api.crossref.org/works/10.1007%2FS00280-008-0704-Z

21 January 2018

Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-008-0704-Z

21 January 2018

Identifiers

10.1007/S00280-008-0704-Z

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40011300&oldid=1882619798"